Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Price Target & Stock Check

In the most recent trading session, Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares saw a move of +0.97%. Covering Wall Street analysts have a consensus target price of $20.00 on the stock. Target predictions might differ vastly from analyst to analyst. This target is applying estimates from analysts polled by Thomson Reuters. 

Sell-side analysts are able to use multiple metrics in order to help calculate target price estimates. A widely used metric is a company’s preice to earnings ratio. This calculation is derived from dividing the current share price by the projected earnings per share. Aldeyra Therapeutics, Inc. currently has a P/E Ratio of N/A. Investors might also evaluate a company’s PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. If a company has a PEG Ratio under one, it may be seen as undervalued. If a company has a PEG Ratio over one, it may represent that the company is overvalued. A PEG Ratio near one may be viewed as fair value. Currently, the company has a PEG Ratio of 0.00.

Looking at stock performance, company shares have recently traded $-1.05 away from the 50-day moving average of $6.25 and $-0.84 away from the 200-day moving average of $6.04. The stock has been recently noted -36.51% off of the 52-week high of 8.19 and +53.39% off of the 52-week low of 3.39. Monitoring the stock price relative to moving averages and highs and lows for the year may help evaluate the value of the stock in the future.